Encourage Epclusa Patients to Refill Their Hepatitis C Med Several Days Early

September 2016

Please see the October 2016 FDA advisory about the risk of Hepatitis B reactivation in some patients being treated for Hepatitis C.

Epclusa (ep-KLOO-suh, sofosbuvir/velpatasvir) will be a new med that further simplifies hepatitis C treatment.

So far, other recent hep C meds (Harvoni, etc) can only be used for certain types of hep C...and duration of treatment can vary.

But Epclusa is a one-tab, once-daily med that can be used for ANY type of hep C...and patients use just a 12-week course.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Medication Errors Alert the Pharmacist When Refrigerated or Frozen Meds Need a Final Check
Testosterone Watch Days' Supply Closely With Natesto Testosterone Gel
Antiepileptics Expect Frequent Dose Changes With Antiseizure Meds to Avoid Side Effects
Epinephrine Watch for Patients Who Forget to Carry Their EpiPen
Practice Engage Patients in Their Own Care to Help Improve Adherence
Influenza Have Patients Fill Out Paper Work Completely so They Get the Right Flu Vaccine
Hepatitis C Encourage Epclusa Patients to Refill Their Hepatitis C Med Several Days Early
Oral Health Be Aware Iron Solutions Can Turn Teeth Surfaces Black
Heart Failure Watch for Heart Failure Patients Taking Supplements
Constipation Expect PEG 3350 to Be Offered Over Docusate for Constipation
HIV & AIDS Watch for HIV Patients Getting Both the Old and New Forms of Tenofovir
Contraceptives Help Women Get the Contraceptive That's Right for Them